Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration

Parasites & Vectors
Yahya A DeruaPaul E Simonsen

Abstract

Lymphatic filariasis (LF) control in most countries of sub-Saharan Africa is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. However, attaining and maintaining high treatment coverage has been a challenge in many LF control programmes. This study was designed to elucidate reasons for continued transmission of LF in an endemic area of Tanga, northeastern Tanzania, where control activities based on MDA had been in place for eight years by the time of this study in 2012. A cross-sectional questionnaire survey was conducted in three sentinel villages used for monitoring the impact of MDA on LF transmission. A total of 747 individuals were interviewed, out of which 172 (23.0%), 27 (3.6%) and 49 (6.5%) had been shown to have circulating filarial antigens (CFA), microfilaraemia (MF) and LF gross lesions, respectively, prior to the interviews. The interviewed population had a mean age of 33.7 years and a male to female ratio of 0.8. Males, individuals aged 30 years and above, peasants/fishermen and recent immigrants to the study communities were significantly more affected (CFA, MF and/ or LF gross lesions) than the other population groups. However, dr...Continue Reading

References

Aug 1, 1996·Tropical Medicine & International Health : TM & IH·K D RamaiahK Ramu
Oct 24, 2000·Tropical Medicine & International Health : TM & IH·E A Ottesen
Mar 13, 2003·Annals of Tropical Medicine and Parasitology·D H Molyneux, N Zagaria
Mar 31, 2004·The Lancet Infectious Diseases·Edwin MichaelJames W Kazura
Mar 28, 2006·Trends in Parasitology·Edwin MichaelJames W Kazura
Jun 1, 2006·Advances in Parasitology·Eric A Ottesen
Nov 28, 2006·Transactions of the Royal Society of Tropical Medicine and Hygiene·Sharmini GunawardenaNadira Karunaweera
Sep 19, 2008·Annual Review of Entomology·Moses J BockarieEdwin Michael
Aug 27, 2009·PLoS Neglected Tropical Diseases·Peter J Hotez, Aruna Kamath
Oct 12, 2010·Acta Tropica·Jonathan D KingPatrick Lammie
Jan 5, 2012·PLoS Neglected Tropical Diseases·Lynne Michelle ZeldenrykWayne Melrose
Nov 6, 2013·The American Journal of Tropical Medicine and Hygiene·Philip J BudgeEls Mathieu
Dec 18, 2013·PLoS Neglected Tropical Diseases·Jeremy D KeenanThomas M Lietman
Jul 6, 2014·Parasites & Vectors·Cédric B ChesnaisMichel Boussinesq
Mar 31, 2015·PLoS Neglected Tropical Diseases·Maria P RebolloMoses J Bockarie
Oct 6, 2016·PLoS Neglected Tropical Diseases·Jean Frantz LemoineMargaret Baker
Sep 25, 2017·Transactions of the Royal Society of Tropical Medicine and Hygiene·Nana-Kwadwo BiritwumJoseph B Koroma

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA
MDAs

Software Mentioned

SPSS
Excel

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.